NY Times columnist David Brooks slams DOGE USAID cuts
All times eastern Fox Report with Jon Scott Fox Report with Jon Scott FOX News Radio Live Channel Coverage
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News24
27 minutes ago
- News24
Cradock Four inquest: Professor Swartz says he is yet to forgive activists' killers
Be among those who shape the future with knowledge. Uncover exclusive stories that captivate your mind and heart with our FREE 14-day subscription trial. Dive into a world of inspiration, learning, and empowerment. You can only trial once. Start your FREE trial now Show Comments ()
Yahoo
an hour ago
- Yahoo
Sky Content Chief Says 'We Had an Amazing Bubble' in Production
The state of U.K. TV production 'has been really tough, and anybody who's been in production these days would echo that,' Cécile Frot-Coutaz, the CEO of Sky Studios and chief content officer of Sky, owned by Comcast, told the Media & Telecoms 2025 & Beyond Conference in London on Tuesday. 'I think it's been tough for a number of reasons,' she shared at the event, organized by Deloitte and Enders Analysis, . 'Less has been commissioned, although I think if you look back over a period of 10 [or 15] years, I'm not sure there's less today…. So, you know, we had an amazing bubble. Everybody got used to the bubble, and obviously now we're sort of coming back down to volumes that are more akin to those that were experienced 15 years ago.' More from The Hollywood Reporter U.K. Culture Secretary Talks AI Regulation at London Media Conference Netflix EMEA Content Boss Touts 'Adolescence,' Debunks a "Myth," Talks Ted Sarandos' Acting Debut Paolo Sorrentino to Receive Sarajevo Film Festival Honor and Retrospective Also, 'there's been a funding issue, because the U.S. hasn't been co-producing British content nearly in the same way, or actually not at all, potentially,' the Sky top executive added. But she also had a silver lining to tout. 'What we're seeing is [that] Europe is actually coming into some shows. We've seen that on some of our own programming. So you have to be very entrepreneurial these days when looking at how to get things financed, unless you're a goal player like Netflix.' About Sky's content output strategy, she highlighted: 'We were never a volume player. So actually, what we've been doing has been very consistent and very steady, and because we're part of the Comcast group, we're able to be flexible on the funding model.' She concluded by predicting that 'looking forward, I think things will settle again. Hopefully, the U.S. will start to come back online.' She made the comments during a panel discussion that also featured Larry Tanz, vp, content, Europe, Middle East and Africa (EMEA) at Netflix, Sarah Rose, president of U.K. broadcaster Channel 5 and U.K. regional lead at Channel 5 owner Paramount Global, and Wayne Garvie, president of Sony Pictures Television. The panel discussed commissioning trends and industry opportunities and challenges. Tuesday's conference also featured top executives from the likes of the Walt Disney Co., U.K. public broadcaster BBC, streaming giant Netflix, and Comcast-owned Sky. Best of The Hollywood Reporter 'The Studio': 30 Famous Faces Who Play (a Version of) Themselves in the Hollywood-Based Series 22 of the Most Shocking Character Deaths in Television History A 'Star Wars' Timeline: All the Movies and TV Shows in the Franchise
Yahoo
an hour ago
- Yahoo
2 Recession-Proof Stocks to Buy and Hold
Even amid an uncertain economic environment, reliable companies can be found. Zoetis helps people care for pets, which many consider as honorary family members. HCA Healthcare offers services in high demand, regardless of economic conditions. 10 stocks we like better than Zoetis › President Trump's trade policies are sparking concerns about a potential recession. Though it's hard to predict an upcoming economic downturn, it's never a bad idea for investors to buy shares of companies that can perform relatively well even in bad times. These corporations often have robust underlying businesses built to deliver consistent results and superior returns over the long run. Here are two great examples for investors to consider: Zoetis (NYSE: ZTS) and HCA Healthcare (NYSE: HCA). Zoetis, a leading animal health company, has faced some challenges over the past year. The company's recent financial results weren't great, and it is dealing with increased competition for some of its growth drivers, including Apoquel, a medicine to treat allergic itch in dogs. However, as Zoetis points out, there is significant whitespace in this niche. It estimates that 13 million dogs are eligible for the medicine but aren't on any prescription, and another 7 million are undertreated. The company currently treats 12 million dogs with Apoquel and Cytopoint, a similar medicine. Although Zoetis markets products for livestock, poultry, and other animals, the company's work with pets, particularly cats and dogs, is one of the primary reasons it can survive a recession relatively unscathed. People view their pets as family members and are more than willing to pay a significant amount to ensure they are well cared for. The increased humanization of pets should also be a significant long-term growth driver for Zoetis, a trend that is particularly prevalent among younger generations, who are less likely to have children than older ones. It might be pushing it to say that pets are the new kids, but it's not too far from the truth for many pet owners. The rest of Zoetis' business grants it significant diversity. The animal health leader generally grows its revenue at rates faster than the industry average, something it has been able to do for a while, despite competition, through the continuous development of newer medicines. Two of its more recent important approvals, Solensia and Librela that treat osteoarthritis pain in cats and dogs, respectively, are becoming key growth drivers, too. So, despite being slightly in the red over the trailing-12-month period, Zoetis is well-equipped to handle a recession if one is coming, while delivering strong returns in the long run. Lastly, the stock is also an excellent pick for income seekers despite its unimpressive forward yield of 1.2%. Zoetis has increased its payouts by 502% in the past decade. Whether it's for dividends or growth, the healthcare specialist is a great option. HCA Healthcare's business remains in high demand even in recessions. The company is a leading hospital chain in the U.S., and even during economic downturns, people still require critical medical care. True, some procedures performed in the company's facilities are optional. Even for those that aren't, patients may sometimes postpone them when things get tough. So, there will be an impact on the company's results, but it should be fairly minimal. Over the past year, the company has faced another source of headwinds. Various natural disasters, including hurricanes, impacted its financial results in some areas, resulting in lower revenue than anticipated. Still, HCA Healthcare continues to deliver decent updates. In the first quarter, the company's revenue increased by a modest 5.7% year over year to $18.3 billion. Its earnings per share came in at $6.45, up 8.8% compared to the year-ago period. Despite this headwind, HCA Healthcare's long-term prospects are attractive. An aging population that will require more medical care should lead to increased spending on precisely the kinds of services it offers. HCA Healthcare has also deepened its relationships with physicians, patients, and third-party payers over time, partly through the adoption of more services. It would be challenging for any newcomer to seriously challenge HCA Healthcare, considering the ecosystem it has already built, which arguably grants it a network effect. Although there is competition, HCA Healthcare has generally increased its market share over the past decade. The stock should continue delivering superior returns long after the next recession hits, whenever that happens. Before you buy stock in Zoetis, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Zoetis wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $668,538!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $869,841!* Now, it's worth noting Stock Advisor's total average return is 789% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Zoetis. The Motley Fool recommends HCA Healthcare. The Motley Fool has a disclosure policy. 2 Recession-Proof Stocks to Buy and Hold was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
